153 related articles for article (PubMed ID: 32621587)
1. Paediatric population pharmacokinetic modelling to assess hydrocortisone replacement dosing regimens in young children.
Michelet R; Melin J; Parra-Guillen ZP; Neumann U; Whitaker JM; Stachanow V; Huisinga W; Porter J; Blankenstein O; Ross RJ; Kloft C
Eur J Endocrinol; 2020 Oct; 183(4):357-368. PubMed ID: 32621587
[TBL] [Abstract][Full Text] [Related]
2. Predicting Cortisol Exposure from Paediatric Hydrocortisone Formulation Using a Semi-Mechanistic Pharmacokinetic Model Established in Healthy Adults.
Melin J; Parra-Guillen ZP; Hartung N; Huisinga W; Ross RJ; Whitaker MJ; Kloft C
Clin Pharmacokinet; 2018 Apr; 57(4):515-527. PubMed ID: 28762136
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic evidence for suboptimal treatment of adrenal insufficiency with currently available hydrocortisone tablets.
Simon N; Castinetti F; Ouliac F; Lesavre N; Brue T; Oliver C
Clin Pharmacokinet; 2010 Jul; 49(7):455-63. PubMed ID: 20528006
[TBL] [Abstract][Full Text] [Related]
4. Bioavailability of oral hydrocortisone in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Charmandari E; Johnston A; Brook CG; Hindmarsh PC
J Endocrinol; 2001 Apr; 169(1):65-70. PubMed ID: 11250647
[TBL] [Abstract][Full Text] [Related]
5. A Prospective Study of Children Aged 0-8 Years with CAH and Adrenal Insufficiency Treated with Hydrocortisone Granules.
Neumann U; Braune K; Whitaker MJ; Wiegand S; Krude H; Porter J; Digweed D; Voet B; Ross RJM; Blankenstein O
J Clin Endocrinol Metab; 2021 Mar; 106(3):e1433-e1440. PubMed ID: 32888021
[TBL] [Abstract][Full Text] [Related]
6. Variability in hydrocortisone plasma and saliva pharmacokinetics following intravenous and oral administration to patients with adrenal insufficiency.
Thomson AH; Devers MC; Wallace AM; Grant D; Campbell K; Freel M; Connell JM
Clin Endocrinol (Oxf); 2007 Jun; 66(6):789-96. PubMed ID: 17437510
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic/Pharmacodynamic Evaluation of Hydrocortisone Therapy in Pediatric Patients with Congenital Adrenal Hyperplasia.
Melin J; Parra-Guillen ZP; Michelet R; Truong T; Huisinga W; Hartung N; Hindmarsh P; Kloft C
J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 32052005
[TBL] [Abstract][Full Text] [Related]
8. Achieving a physiological cortisol profile with once-daily dual-release hydrocortisone: a pharmacokinetic study.
Johannsson G; Lennernäs H; Marelli C; Rockich K; Skrtic S
Eur J Endocrinol; 2016 Jul; 175(1):85-93. PubMed ID: 27129362
[TBL] [Abstract][Full Text] [Related]
9. Weight-related dosing, timing and monitoring hydrocortisone replacement therapy in patients with adrenal insufficiency.
Mah PM; Jenkins RC; Rostami-Hodjegan A; Newell-Price J; Doane A; Ibbotson V; Tucker GT; Ross RJ
Clin Endocrinol (Oxf); 2004 Sep; 61(3):367-75. PubMed ID: 15355454
[TBL] [Abstract][Full Text] [Related]
10. Replacement therapy of oral hydrocortisone in adrenal insufficiency: the influence of gastrointestinal factors.
Lennernäs H; Skrtic S; Johannsson G
Expert Opin Drug Metab Toxicol; 2008 Jun; 4(6):749-58. PubMed ID: 18611115
[TBL] [Abstract][Full Text] [Related]
11. Development and verification of an endogenous PBPK model to inform hydrocortisone replacement dosing in children and adults with cortisol deficiency.
Bonner JJ; Burt H; Johnson TN; Whitaker MJ; Porter J; Ross RJ
Eur J Pharm Sci; 2021 Oct; 165():105913. PubMed ID: 34146682
[TBL] [Abstract][Full Text] [Related]
12. Absorption and tolerability of taste-masked hydrocortisone granules in neonates, infants and children under 6 years of age with adrenal insufficiency.
Neumann U; Whitaker MJ; Wiegand S; Krude H; Porter J; Davies M; Digweed D; Voet B; Ross RJ; Blankenstein O
Clin Endocrinol (Oxf); 2018 Jan; 88(1):21-29. PubMed ID: 28815660
[TBL] [Abstract][Full Text] [Related]
13. Immediate-release granule formulation of hydrocortisone, Alkindi®, for treatment of paediatric adrenal insufficiency (Infacort development programme).
Porter J; Withe M; Ross RJ
Expert Rev Endocrinol Metab; 2018 May; 13(3):119-124. PubMed ID: 30058902
[TBL] [Abstract][Full Text] [Related]
14. Optimal glucocorticoid therapy.
Debono M; Ross RJ
Endocr Dev; 2011; 20():173-180. PubMed ID: 21164270
[TBL] [Abstract][Full Text] [Related]
15. Elevated hair cortisol concentrations in children with adrenal insufficiency on hydrocortisone replacement therapy.
Noppe G; van Rossum EF; Vliegenthart J; Koper JW; van den Akker EL
Clin Endocrinol (Oxf); 2014 Dec; 81(6):820-5. PubMed ID: 25039686
[TBL] [Abstract][Full Text] [Related]
16. Plasma, salivary and urinary cortisol levels following physiological and stress doses of hydrocortisone in normal volunteers.
Jung C; Greco S; Nguyen HH; Ho JT; Lewis JG; Torpy DJ; Inder WJ
BMC Endocr Disord; 2014 Nov; 14():91. PubMed ID: 25425285
[TBL] [Abstract][Full Text] [Related]
17. Development and testing in healthy adults of oral hydrocortisone granules with taste masking for the treatment of neonates and infants with adrenal insufficiency.
Whitaker MJ; Spielmann S; Digweed D; Huatan H; Eckland D; Johnson TN; Tucker G; Krude H; Blankenstein O; Ross RJ
J Clin Endocrinol Metab; 2015 Apr; 100(4):1681-8. PubMed ID: 25646792
[TBL] [Abstract][Full Text] [Related]
18. European Adrenal Insufficiency Registry (EU-AIR): a comparative observational study of glucocorticoid replacement therapy.
Ekman B; Fitts D; Marelli C; Murray RD; Quinkler M; Zelissen PM
BMC Endocr Disord; 2014 May; 14():40. PubMed ID: 24884782
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of oral hydrocortisone - Results and implications from a randomized controlled trial.
Werumeus Buning J; Touw DJ; Brummelman P; Dullaart RPF; van den Berg G; van der Klauw MM; Kamp J; Wolffenbuttel BHR; van Beek AP
Metabolism; 2017 Jun; 71():7-16. PubMed ID: 28521880
[TBL] [Abstract][Full Text] [Related]
20. Is physiological glucocorticoid replacement important in children?
Porter J; Blair J; Ross RJ
Arch Dis Child; 2017 Feb; 102(2):199-205. PubMed ID: 27582458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]